Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Organizational Objectives × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Obesity 1 Neoplasms 1

Interventions

Cisplatin 860 Cyclophosphamide 810 Carboplatin 805 Radiotherapy 752 Bevacizumab 706 Gemcitabine 679 pembrolizumab 635 Docetaxel 634 Paclitaxel 621 Oxaliplatin 586 Capecitabine 547 Fluorouracil 487 Rituximab 478 Nivolumab 422 Dexamethasone 416 Etoposide 393 Doxorubicin 382 Irinotecan 378 Drug Therapy 327 Leucovorin 323 Cytarabine 297 Cetuximab 285 Lenalidomide 279 Trastuzumab 275 Pemetrexed 270 durvalumab 245 Filgrastim 242 Prednisone 229 Temozolomide 227 Magnetic Resonance Spectroscopy 224

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01004094 2016-01-20

SQ!II

Baylor College of Medicine

Phase 2 Completed

Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡